alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-D-Galp

Term ID

CHEBI:146043

Synonyms

(2S,3S,4R,5S,6S)-2-[(2S,3R,4S,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[(3R,4S,5S,6R)-2,3,5-trihydroxy-6-(hydroxymethyl)oxan-4-yl]oxyoxan-3-yl]oxy-6-methyloxane-3,4,5-triol
6-deoxy-alpha-L-galacto-hexopyranosyl-(1->2)-beta-D-galacto-hexopyranosyl-(1->3)-D-galacto-hexopyranose
6-deoxy-alpha-L-galactopyranosyl-(1->2)-beta-D-galactopyranosyl-(1->3)-D-galactopyranose
6-deoxy-alpha-L-Galp-(1->2)-beta-D-Galp-(1->3)-D-Galp
Fuc(a1-2)Gal(b1-3)Gal
WURCS=2.0/3,3,2/[a2112h-1x_1-5][a2112h-1b_1-5][a1221m-1a_1-5]/1-2-3/a3-b1_b2-c1

Definition

A trisaccharide consisting of D-galactose at the reducing end having an alpha-L-fucosyl-(1->2)-beta-D-galactosyl moiety attached at the 3-position.

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: trisaccharide

trisaccharide Show first 5 Terms
has subtype: alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-beta-D-Galp

alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-beta-D-Galp Show first 5 Terms

Phenotype

Phenotype resulting from alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-D-Galp

Phenotype where environments contain alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-D-Galp

Phenotype modified by environments containing alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-D-Galp

Human Disease Model